Matches in SemOpenAlex for { <https://semopenalex.org/work/W2768275731> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2768275731 endingPage "251" @default.
- W2768275731 startingPage "247" @default.
- W2768275731 abstract "Background Treatment of heart failure with reduced ejection fraction (HFrEF) requires guideline-directed medication therapy (GDMT) consisting of either an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker in combination with an indicated beta-blocker. There is concern that end-stage renal disease (ESRD) patients are not being prescribed GDMT. The study aim was to determine whether outcomes differ for patients with HFrEF and ESRD receiving GDMT compared to those not receiving GDMT. Materials and Methods Adult patients with ESRD and HFrEF admitted to a tertiary teaching hospital over a 2-year period were included. Patients were categorized into GDMT or non-GDMT groups based on their home medications. The length of stay (LOS), mortality, and 30-day hospital readmissions were compared between groups. The incidence of hyperkalemia, hypotension and bradycardia were also evaluated. Results A total of 109 patients were included: 88% African-American, 61% males, median age 63 (28-93) years with 25 in the GDMT group and 84 in the non-GDMT group. The LOS did not differ between the GDMT (5 days; 3-14) compared to the non-GDMT group (7 days; 3-28), P = 0.14. Thirty-day hospital readmission and in-hospital mortality were also similar. Hypotension occurred less frequently in the GDMT group compared to the non-GDMT group, 4% versus 27% (P = 0.01). Conclusions Although there were no differences in the primary outcomes, the shorter LOS in the GDMT group may be clinically significant. The fact that most patients with ESRD and HFrEF were not receiving GDMT is a finding that requires further evaluation." @default.
- W2768275731 created "2017-12-04" @default.
- W2768275731 creator A5012980787 @default.
- W2768275731 creator A5028629744 @default.
- W2768275731 creator A5045895604 @default.
- W2768275731 creator A5053260748 @default.
- W2768275731 creator A5054800790 @default.
- W2768275731 creator A5076634576 @default.
- W2768275731 date "2018-03-01" @default.
- W2768275731 modified "2023-10-18" @default.
- W2768275731 title "Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease" @default.
- W2768275731 cites W1543589545 @default.
- W2768275731 cites W2056893352 @default.
- W2768275731 cites W2085106652 @default.
- W2768275731 cites W2095709130 @default.
- W2768275731 cites W2126841678 @default.
- W2768275731 cites W2152004522 @default.
- W2768275731 cites W2164705414 @default.
- W2768275731 cites W2169967457 @default.
- W2768275731 cites W2178738676 @default.
- W2768275731 cites W2323458614 @default.
- W2768275731 cites W2381016711 @default.
- W2768275731 doi "https://doi.org/10.1016/j.amjms.2017.11.008" @default.
- W2768275731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29549927" @default.
- W2768275731 hasPublicationYear "2018" @default.
- W2768275731 type Work @default.
- W2768275731 sameAs 2768275731 @default.
- W2768275731 citedByCount "3" @default.
- W2768275731 countsByYear W27682757312020 @default.
- W2768275731 countsByYear W27682757312021 @default.
- W2768275731 countsByYear W27682757312023 @default.
- W2768275731 crossrefType "journal-article" @default.
- W2768275731 hasAuthorship W2768275731A5012980787 @default.
- W2768275731 hasAuthorship W2768275731A5028629744 @default.
- W2768275731 hasAuthorship W2768275731A5045895604 @default.
- W2768275731 hasAuthorship W2768275731A5053260748 @default.
- W2768275731 hasAuthorship W2768275731A5054800790 @default.
- W2768275731 hasAuthorship W2768275731A5076634576 @default.
- W2768275731 hasConcept C120665830 @default.
- W2768275731 hasConcept C121332964 @default.
- W2768275731 hasConcept C126322002 @default.
- W2768275731 hasConcept C126894567 @default.
- W2768275731 hasConcept C141071460 @default.
- W2768275731 hasConcept C2778198053 @default.
- W2768275731 hasConcept C61511704 @default.
- W2768275731 hasConcept C65409693 @default.
- W2768275731 hasConcept C71924100 @default.
- W2768275731 hasConcept C78085059 @default.
- W2768275731 hasConceptScore W2768275731C120665830 @default.
- W2768275731 hasConceptScore W2768275731C121332964 @default.
- W2768275731 hasConceptScore W2768275731C126322002 @default.
- W2768275731 hasConceptScore W2768275731C126894567 @default.
- W2768275731 hasConceptScore W2768275731C141071460 @default.
- W2768275731 hasConceptScore W2768275731C2778198053 @default.
- W2768275731 hasConceptScore W2768275731C61511704 @default.
- W2768275731 hasConceptScore W2768275731C65409693 @default.
- W2768275731 hasConceptScore W2768275731C71924100 @default.
- W2768275731 hasConceptScore W2768275731C78085059 @default.
- W2768275731 hasIssue "3" @default.
- W2768275731 hasLocation W27682757311 @default.
- W2768275731 hasLocation W27682757312 @default.
- W2768275731 hasOpenAccess W2768275731 @default.
- W2768275731 hasPrimaryLocation W27682757311 @default.
- W2768275731 hasRelatedWork W1967116681 @default.
- W2768275731 hasRelatedWork W1971710084 @default.
- W2768275731 hasRelatedWork W2047967234 @default.
- W2768275731 hasRelatedWork W2072108749 @default.
- W2768275731 hasRelatedWork W2378202933 @default.
- W2768275731 hasRelatedWork W2481234813 @default.
- W2768275731 hasRelatedWork W2891746874 @default.
- W2768275731 hasRelatedWork W3155674270 @default.
- W2768275731 hasRelatedWork W4206264227 @default.
- W2768275731 hasRelatedWork W4207030337 @default.
- W2768275731 hasVolume "355" @default.
- W2768275731 isParatext "false" @default.
- W2768275731 isRetracted "false" @default.
- W2768275731 magId "2768275731" @default.
- W2768275731 workType "article" @default.